Host factor targeting newly developed treatment for HCV
Project/Area Number |
21590860
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Showa University |
Principal Investigator |
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2011: ¥130,000 (Direct Cost: ¥100,000、Indirect Cost: ¥30,000)
Fiscal Year 2010: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2009: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | HCV / サイクロフィリン / 宿主因子 / 抗ウイルス剤 |
Research Abstract |
About 200million people are suffering from Hepatitis C virus infection that leads to hepatocellular carcinoma and chronic liver failure. Effectiveness of standard of care is not so sufficient to cure the intractable cases. We have searched for new lead compound targeting host factor that is related to HCV replication using new peptide library. Now we are characterizing new compounds.
|
Report
(4 results)
Research Products
(19 results)